HS
HRTX icon

Horan Securities’s Heron Therapeutics HRTX Stock Holding History

Horan Securities’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$86.1K Hold
41,590
– – 0.03% 152
2025
Q1 		$91.5K Buy
+41,590
New +$80.7K 0.03% 134
2024
Q4 		– Sell
-29,310
Closed -$58.3K – 134
2024
Q3 		$58.3K Hold
29,310
– – 0.02% 140
2024
Q2 		$103K Buy
+29,310
New +$90K 0.04% 123

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $2.3B AUM 29.92% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Horan Securities's HRTX Position: Q2 2025 in Review

Horan Securities held its Heron Therapeutics (HRTX) position steady in Q2 2025 at 41,590 shares worth $86.1K. The position accounts for 0.03% of the portfolio, ranked #152.

Horan Securities first reported a position in HRTX in Q2 2024 and has held it in 4 quarters since. The position peaked at $103K in Q2 2024. 171 funds tracked by Wall St. Rank hold HRTX as of Q2 2025.

  • Horan Securities held 41,590 shares of Heron Therapeutics worth $86.1K as of Q2 2025.
  • Horan Securities left its Heron Therapeutics share count unchanged in Q2 2025.
  • Heron Therapeutics made up 0.03% of Horan Securities's portfolio in Q2 2025, its #152 holding.
  • Horan Securities first reported a position in Heron Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • Horan Securities's Heron Therapeutics position peaked at $103K in Q2 2024.
  • 171 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2025.

Based on Horan Securities's 13F filing for Q2 2025, filed 6 Aug 2025.